API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.indianpharmapost.com/news/glenmark-to-launch-a-triple-drug-fdc-of-teneligliptin-dapagliflozin-metformin-in-india-for-type-2-diabetes-14798
https://health.economictimes.indiatimes.com/news/pharma/anti-diabetes-drugs-and-patented-antivirals-to-get-cheaper-nlem-notified/95483953
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-launches-drug-for-diabetic-patients-with-comorbidities/articleshow/94981411.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://pink.pharmaintelligence.informa.com/PS147023/Pharma-Readies-For-Price-Caps-On-Glargine-Teneligliptin-Lenalidomide-In-India
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-patented-tb-hiv-drugs-enter-essential-list/articleshow/94185393.cms
https://health.economictimes.indiatimes.com/news/pharma/glenmark-becomes-the-first-pharmaceutical-company-to-launch-teneligliptin-pioglitazone-fixed-dose-combination-drug-for-type-2-diabetes-in-india/91112044
https://www.biospectrumasia.com/news/25/16053/mitsubishi-tanabe-receives-marketing-approval-for-diabetes-drug-in-thailand.html
https://www.biospectrumasia.com/news/56/16053/mitsubishi-tanabe-receives-marketing-approval-for-diabetes-drug-in-thailand.html